Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
CRON 
Cronos Group Inc (CRON)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
07/10/2025: CRON (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
5 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $2.21
1 Year Target Price $2.21
| 1 | Strong Buy |
| 1 | Buy |
| 2 | Hold |
| 1 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -27.52% | Avg. Invested days 29 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 07/10/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 811.26M USD | Price to earnings Ratio 15 | 1Y Target Price 2.21 |
Price to earnings Ratio 15 | 1Y Target Price 2.21 | ||
Volume (30-day avg) 5 | Beta 1.52 | 52 Weeks Range 1.60 - 2.54 | Updated Date 07/10/2025 |
52 Weeks Range 1.60 - 2.54 | Updated Date 07/10/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.14 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 39.69% | Operating Margin (TTM) -10.9% |
Management Effectiveness
Return on Assets (TTM) -2.42% | Return on Equity (TTM) 4.59% |
Valuation
Trailing PE 15 | Forward PE - | Enterprise Value -32468314 | Price to Sales(TTM) 6.51 |
Enterprise Value -32468314 | Price to Sales(TTM) 6.51 | ||
Enterprise Value to Revenue 0.02 | Enterprise Value to EBITDA -1.42 | Shares Outstanding 385419008 | Shares Floating 204815522 |
Shares Outstanding 385419008 | Shares Floating 204815522 | ||
Percent Insiders 46.73 | Percent Institutions 14.32 |
Upturn AI SWOT
Cronos Group Inc
Company Overview
History and Background
Cronos Group Inc. was founded in 2012 and is headquartered in Toronto, Canada. It's a global cannabinoid company committed to improving lives through cannabis. It has undergone significant expansion and strategic partnerships since its inception.
Core Business Areas
- Dried Cannabis: Production and distribution of dried cannabis flowers for recreational and medical use.
- Oils and Concentrates: Production and distribution of cannabis oils and concentrates for various applications, including vaping and edibles.
- Edibles: Production and distribution of cannabis-infused edibles, such as gummies and chocolates.
- Vaporizers: Sales of vaporizers for cannabis consumption.
- Strategic Partnership: Strategic partnership with Ginkgo Bioworks to produce cultured cannabinoids at scale.
Leadership and Structure
Cronos Group Inc's leadership team includes key executives in areas such as CEO, CFO, and Chief Legal Officer. The organizational structure is typical of a publicly traded company, with various departments responsible for research, production, sales, and marketing.
Top Products and Market Share
Key Offerings
- Spinach: Spinach is one of Cronos' key brands in the Canadian recreational market. Market share data varies but they are considered to be in top 3-5 brands. Competitors include Canopy Growth (CGC), Tilray (TLRY).
- Peace Naturals: Peace Naturals is a brand focused on medical cannabis. Market data is limited, but they aim to provide consistent, high-quality medical cannabis. Competitors are similar to Spinach, with added focus on medical brands such as Aurora Cannabis (ACB).
- Lord Jones: Lord Jones is a luxury CBD brand in the US. Market share in this sector is competitive. Competitors include Charlotte's Web (CWBHF).
Market Dynamics
Industry Overview
The cannabis industry is experiencing growth but also faces regulatory hurdles and intense competition. It involves the cultivation, processing, distribution, and retail of cannabis products for both medical and recreational use.
Positioning
Cronos Group Inc. is positioned as a global cannabinoid company with a focus on branded products and innovative research. The company is competing with other big market cap cannabis companies for market share.
Total Addressable Market (TAM)
The global cannabis market is projected to reach hundreds of billions in the coming years. Cronos Group Inc. aims to capture a significant share through brand building and innovative products.
Upturn SWOT Analysis
Strengths
- Strong Brand Portfolio
- Partnership with Altria Group (MO)
- Focus on Innovation
- Global Presence
Weaknesses
- Limited Profitability
- High Operating Expenses
- Dependence on Regulatory Changes
- Market Volatility
Opportunities
- Expansion into New Markets
- Development of New Products
- Increased Legalization
- Growing Consumer Acceptance
Threats
- Intense Competition
- Regulatory Uncertainty
- Price Volatility
- Changing Consumer Preferences
Competitors and Market Share
Key Competitors
- TLRY
- CGC
- ACB
- CWBHF
Competitive Landscape
Cronos Group Inc. competes in a highly competitive market. The companyu2019s advantages include a strong brand portfolio and partnership with Altria. Disadvantages include limited profitability and market volatility.
Major Acquisitions
Lord Jones
- Year: 2019
- Acquisition Price (USD millions): 300
- Strategic Rationale: Expansion into the U.S. CBD market with a luxury brand.
Growth Trajectory and Initiatives
Historical Growth: Cronos Group Inc. has demonstrated revenue growth in past years, driven by increasing sales and market expansion. However, the company still struggles with profitability.
Future Projections: Future growth depends on further legalization and market penetration. Analyst estimates vary widely depending on changing regulatory conditions.
Recent Initiatives: Recent initiatives include product innovation, market expansion, and partnerships to scale production and distribution.
Summary
Cronos Group Inc. is navigating a challenging and evolving cannabis industry. Its partnership with Altria provides financial stability and market access. However, the company needs to improve profitability and navigate regulatory uncertainties. Cronos shows promise in innovating and establishing a strong market presence but its success hinges on how well the company handles its weaknesses and external threats.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Filings (SEC)
- Market Research Reports
- Analyst Estimates
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Market conditions and company-specific events may impact the accuracy of the data.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Cronos Group Inc
Exchange NASDAQ | Headquaters Stayner, ON, Canada | ||
IPO Launch date 2016-07-12 | President, CEO & Chairman Mr. Michael Ryan Gorenstein J.D. | ||
Sector Healthcare | Industry Drug Manufacturers - Specialty & Generic | Full time employees 459 | Website https://thecronosgroup.com |
Full time employees 459 | Website https://thecronosgroup.com | ||
Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brand names. The company is based in Stayner, Canada.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.